SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivanza Biosciences informs about outcome of Board Meeting

01 Jul 2023 Evaluate

Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with Schedule III to the Listing Regulations, Vivanza Biosciences has informed that the Board of Directors of the Company, at its Meeting held today, on Friday, June 30, 2023 at registered Office of the Company, has: Considered and approved the Director’s report and secretarial Audit Report along with annexure for the Financial Year ended 31st March, 2023,  Considered and approved Appointment of Chintan K. Patel, Company Secretary as a Secretarial Auditor of the Company for the Financial Year 2023-24, Considered and approved the proposal regarding regularization of Apeksha Vyas (DIN: 09469295) as Non-Executive Independent Director of the Company in the ensuing Annual General Meeting, Approved the draft notice of 41st Annual General Meeting (AGM), which is scheduled to be held on Monday, 24st July, 2023 at 03:00 pm, Considered that the Book Closure date for the purpose of 41st Annual General Meeting (AGM) is fixed from Tuesday, 18th July, 2023 to Monday, 24th July, 2023, Considered and approved the Appointment of Chintan Patel, Company Secretary in Practice as a Scrutinizer to ascertain Voting Process of 41st Annual General Meeting (AGM), Considered and approved the borrowing to be increased to Rs 20,00,00,000 subject to approval of members in the ensuing Annual General Meeting and Considered and approved the proposal regarding regularization of Jayendra Mehta (DIN: 08210602) as Managing Director of the Company in the ensuing Annual General Meeting. The Meeting has been commenced at 05:00 pm and concluded at 05:30 pm.

The above information is a part of company’s filings submitted to BSE.

Vivanza Biosciences Share Price

2.07 -0.03 (-1.43%)
20-Apr-2026 16:02 View Price Chart
Peers
Company Name CMP
Redington 227.50
Adani Enterprises 2228.00
Amrapali Industries 17.36
Rashi Peripheral 471.55
PDS 292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×